Ortivus AB (publ) (ORTI-B.ST)
SEK 1.48
(-6.62%)
SEK 1.48
(-6.62%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 72.7 Million SEK | -18.99% |
| 2022 | 89.75 Million SEK | 23.86% |
| 2021 | 72.45 Million SEK | 8.88% |
| 2020 | 66.55 Million SEK | 90.47% |
| 2019 | 34.94 Million SEK | 26.15% |
| 2018 | 27.69 Million SEK | -19.81% |
| 2017 | 34.54 Million SEK | -26.89% |
| 2016 | 47.24 Million SEK | -28.46% |
| 2015 | 66.04 Million SEK | -20.24% |
| 2014 | 82.8 Million SEK | 125.13% |
| 2013 | 36.78 Million SEK | -30.85% |
| 2012 | 53.19 Million SEK | 4.23% |
| 2011 | 51.03 Million SEK | -38.89% |
| 2010 | 83.5 Million SEK | -49.12% |
| 2009 | 164.13 Million SEK | -9.46% |
| 2008 | 181.27 Million SEK | -28.48% |
| 2007 | 253.44 Million SEK | -24.09% |
| 2006 | 333.89 Million SEK | -6.28% |
| 2005 | 356.26 Million SEK | 37.62% |
| 2004 | 258.87 Million SEK | -1.34% |
| 2003 | 262.38 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 66.93 Million SEK | -7.94% |
| 2024 Q2 | 63.93 Million SEK | -4.48% |
| 2023 Q3 | 71.84 Million SEK | -4.84% |
| 2023 FY | 72.7 Million SEK | -18.99% |
| 2023 Q2 | 75.49 Million SEK | -15.22% |
| 2023 Q1 | 89.05 Million SEK | -0.78% |
| 2023 Q4 | 72.7 Million SEK | 1.2% |
| 2022 FY | 89.75 Million SEK | 23.86% |
| 2022 Q4 | 89.75 Million SEK | 35.69% |
| 2022 Q2 | 80.18 Million SEK | 10.39% |
| 2022 Q1 | 72.63 Million SEK | 0.24% |
| 2022 Q3 | 66.14 Million SEK | -17.51% |
| 2021 FY | 72.45 Million SEK | 8.88% |
| 2021 Q2 | 68.68 Million SEK | -11.56% |
| 2021 Q4 | 72.45 Million SEK | -1.33% |
| 2021 Q3 | 73.43 Million SEK | 6.92% |
| 2021 Q1 | 77.65 Million SEK | 16.69% |
| 2020 Q3 | 62.09 Million SEK | -13.55% |
| 2020 Q4 | 66.55 Million SEK | 7.18% |
| 2020 Q1 | 50.47 Million SEK | 44.47% |
| 2020 Q2 | 71.82 Million SEK | 42.28% |
| 2020 FY | 66.55 Million SEK | 90.47% |
| 2019 Q3 | 29.88 Million SEK | -18.18% |
| 2019 FY | 34.94 Million SEK | 26.15% |
| 2019 Q1 | 32.84 Million SEK | 18.6% |
| 2019 Q2 | 36.52 Million SEK | 11.18% |
| 2019 Q4 | 34.94 Million SEK | 16.93% |
| 2018 Q4 | 27.69 Million SEK | -9.13% |
| 2018 Q2 | 31.29 Million SEK | -7.9% |
| 2018 FY | 27.69 Million SEK | -19.81% |
| 2018 Q1 | 33.97 Million SEK | -1.62% |
| 2018 Q3 | 30.47 Million SEK | -2.61% |
| 2017 Q4 | 34.54 Million SEK | -8.43% |
| 2017 Q1 | 42.74 Million SEK | -9.53% |
| 2017 FY | 34.54 Million SEK | -26.89% |
| 2017 Q2 | 46.41 Million SEK | 8.6% |
| 2017 Q3 | 37.72 Million SEK | -18.74% |
| 2016 Q4 | 47.24 Million SEK | -22.63% |
| 2016 FY | 47.24 Million SEK | -28.46% |
| 2016 Q2 | 61.18 Million SEK | -8.99% |
| 2016 Q1 | 67.23 Million SEK | 1.79% |
| 2016 Q3 | 61.06 Million SEK | -0.19% |
| 2015 Q1 | 85.02 Million SEK | 2.68% |
| 2015 FY | 66.04 Million SEK | -20.24% |
| 2015 Q3 | 74.79 Million SEK | -17.99% |
| 2015 Q4 | 66.04 Million SEK | -11.7% |
| 2015 Q2 | 91.19 Million SEK | 7.26% |
| 2014 Q4 | 82.8 Million SEK | 8.64% |
| 2014 Q2 | 57.23 Million SEK | 42.02% |
| 2014 FY | 82.8 Million SEK | 125.13% |
| 2014 Q3 | 76.22 Million SEK | 33.18% |
| 2014 Q1 | 40.29 Million SEK | 9.56% |
| 2013 Q4 | 36.78 Million SEK | 1.89% |
| 2013 Q1 | 46.34 Million SEK | -12.86% |
| 2013 Q2 | 39.53 Million SEK | -14.69% |
| 2013 FY | 36.78 Million SEK | -30.85% |
| 2013 Q3 | 36.09 Million SEK | -8.71% |
| 2012 FY | 53.19 Million SEK | 4.23% |
| 2012 Q1 | 63.8 Million SEK | 25.03% |
| 2012 Q2 | 48.56 Million SEK | -23.88% |
| 2012 Q3 | 46.48 Million SEK | -4.28% |
| 2012 Q4 | 53.19 Million SEK | 14.42% |
| 2011 Q3 | 58.27 Million SEK | -13.55% |
| 2011 FY | 51.03 Million SEK | -38.89% |
| 2011 Q1 | 75.46 Million SEK | -9.64% |
| 2011 Q2 | 67.41 Million SEK | -10.67% |
| 2011 Q4 | 51.03 Million SEK | -12.43% |
| 2010 Q4 | 83.5 Million SEK | 0.0% |
| 2010 FY | 83.5 Million SEK | -49.12% |
| 2009 FY | 164.13 Million SEK | -9.46% |
| 2008 FY | 181.27 Million SEK | -28.48% |
| 2007 FY | 253.44 Million SEK | -24.09% |
| 2006 FY | 333.89 Million SEK | -6.28% |
| 2005 FY | 356.26 Million SEK | 37.62% |
| 2004 FY | 258.87 Million SEK | -1.34% |
| 2003 FY | 262.38 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AddLife AB (publ) | 12.74 Billion SEK | 99.43% |
| Biotage AB (publ) | 4.93 Billion SEK | 98.526% |
| Bonesupport Holding AB (publ) | 688.81 Million SEK | 89.445% |
| Doxa AB (publ) | 3.75 Billion SEK | 98.064% |
| Elekta AB (publ) | 31.41 Billion SEK | 99.769% |
| iZafe Group AB (publ) | 34.61 Million SEK | -110.048% |
| Ortivus AB (publ) | 72.7 Million SEK | 0.0% |
| Q-linea AB (publ) | 231.97 Million SEK | 68.658% |
| S2Medical AB (publ) | 21.4 Million SEK | -239.63% |
| Synsam AB (publ) | 8.03 Billion SEK | 99.095% |